Corient Private Wealth
CALC icon

Corient Private Wealth’s CalciMedica CALC Stock Holding History

Corient Private Wealth’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-38,000
Closed -$60.8K – 2573
2025
Q2 		$60.8K Hold
38,000
– – ﹤0.01% 2372
2025
Q1 		$72.6K Hold
38,000
– – ﹤0.01% 2203
2024
Q4 		$135K Buy
+38,000
New +$133K ﹤0.01% 2189

Other funds holding CALC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
SSIM
Sheets Smith Investment Management Houston, Texas $154M AUM 66.97% 1-Year Est. Return

Corient Private Wealth's CALC Position: Q3 2025 in Review

Corient Private Wealth sold out of CalciMedica (CALC) in Q3 2025, closing a stake of 38,000 shares — an estimated $60.8K sold.

Corient Private Wealth first reported a position in CALC in Q4 2024 and held it in 3 quarters. The position peaked at $135K in Q4 2024. 31 funds tracked by Wall St. Rank hold CALC as of Q3 2025.

  • Corient Private Wealth reported no remaining CalciMedica position as of Q3 2025 after selling out during the quarter.
  • Corient Private Wealth sold 38,000 CalciMedica shares in Q3 2025, an estimated $60.8K.
  • Corient Private Wealth first reported a position in CalciMedica in Q4 2024 and held it in 3 quarters.
  • Corient Private Wealth's CalciMedica position peaked at $135K in Q4 2024.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q3 2025.

Based on Corient Private Wealth's 13F filing for Q3 2025, filed 14 Nov 2025.